RadiotherapyRadiotherapy DosageRadiotherapy, AdjuvantRadiotherapy, ConformalAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyRadiotherapy, High-EnergyRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedEnergy MetabolismChemotherapy, AdjuvantDose FractionationRadiation InjuriesTreatment OutcomeRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedEnergy IntakeCisplatinNeoplasm StagingDisease-Free SurvivalNeoplasm Recurrence, LocalAntineoplastic AgentsRadiation OncologyDose-Response Relationship, RadiationPhosphocreatineSurvival RateSurvival AnalysisHead and Neck NeoplasmsLung NeoplasmsParticle AcceleratorsPrognosisChemoradiotherapyRadiosurgeryBreast NeoplasmsDoxorubicinBrachytherapyNeoadjuvant TherapyCyclophosphamideBrain NeoplasmsCarcinoma, Squamous CellFollow-Up StudiesEnergy TransferTime FactorsNasopharyngeal NeoplasmsRadiation ToleranceNeoplasmsRectal NeoplasmsCranial IrradiationRadiometryHodgkin DiseaseEtoposideRadiation-Sensitizing AgentsOrgans at RiskRetrospective StudiesDrug Administration ScheduleDacarbazineVinblastineCarcinoma, Non-Small-Cell LungBleomycinHeavy IonsAdenocarcinomaProstatic NeoplasmsCarboplatinSalvage TherapyRadiation PneumonitisAntineoplastic Agents, AlkylatingRadiation DosageMethotrexateTomography, X-Ray ComputedNeoplasms, Second PrimaryMastectomy, SegmentalPelvic NeoplasmsAdenosine TriphosphatePalliative CareLaryngeal NeoplasmsKaplan-Meier EstimateProspective StudiesCarcinomaNeoplasms, Radiation-InducedRadiodermatitisLinear Energy TransferNeoplasm MetastasisInduction ChemotherapyLymphatic MetastasisAntimetabolites, AntineoplasticPaclitaxelHeavy Ion RadiotherapyPhosphatesDeoxycytidineOrgan Sparing TreatmentsLomustineVincristineXerostomiaIfosfamideBone NeoplasmsRelative Biological EffectivenessTesticular NeoplasmsProcarbazineMastectomyRadioisotope Teletherapy